MoneyWorks4Me

The Revenue for the quarter ended  June 2026 of Rs. 3922.75 millions grew by 18.00 % from Rs. 3324.43 millions.The Net proft of the company remain more or less same to Rs. 448.39  millions from Rs. 448.67 millions ,decline by -0.06%.Operating profit for the quarter ended June 2026 rose to 746.07 millions as compared to 726.63 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3922.75 3324.43 18.00 3922.75 3324.43 18.00 13487.36 13117.84 2.82
Other Income 261.04 285.55 -8.58 261.04 285.55 -8.58 1129.65 1241.92 -9.04
PBIDT 746.07 726.63 2.68 746.07 726.63 2.68 2104.25 2626.91 -19.90
Interest 24.76 29.11 -14.94 24.76 29.11 -14.94 100.38 153.09 -34.43
PBDT 721.31 697.52 3.41 721.31 697.52 3.41 1938.68 2473.82 -21.63
Depreciation 127.95 102.46 24.88 127.95 102.46 24.88 455.03 395.45 15.07
PBT 593.36 595.06 -0.29 593.36 595.06 -0.29 1483.65 2078.37 -28.61
TAX 144.97 146.39 -0.97 144.97 146.39 -0.97 367.25 468.39 -21.59
Deferred Tax -8.53 -15.84 -46.15 -8.53 -15.84 -46.15 -3.69 -7.14 -48.32
PAT 448.39 448.67 -0.06 448.39 448.67 -0.06 1116.40 1609.98 -30.66
Equity 306.21 306.21 0.00 306.21 306.21 0.00 306.21 306.21 0.00
PBIDTM(%) 19.02 21.86 -12.99 19.02 21.86 -12.99 15.60 20.03 -22.09
Peers
Company Name CMP
Sun Pharma. Inds. 1792.50
Dr. Reddys Labs. 1198.10
Cipla 1327.50
Lupin 2009.60
Zydus Lifesciences 1144.75
View more..